As well as decreased olfactory function, post mortem studies have demonstrated the presence of amyloid-beta (Aβ) and hyperphosphorylated tau (key products in the two major AD pathological hallmarks; Attems et al., 2014) in the olfactory system. The gene discussed is MAPT; the disease is Alzheimer disease.